September 13, 2024 is the 13th World Sepsis Day, and since the first World Spesis Day (WSD) was established in 2012, the global healthcare community and the public have been raising awareness of this serious and life-threatening disease year by year. On this day, we once again focused on sepsis, aiming to further raise public awareness of sepsis through scientific education and other activities, r...
The bactericidal ability of HBP as well as the heparin-binding ability are related to its strong positive charge. HBP, as a chemotactic substance, can activate monocytes and macrophages, induce vascular leakage and tissue edema. Inactivating HBP blocks endothelial hyperosmocyte hyperpermeability caused by neutrophils. At present, HBP, as an acute phase protein, is an effective biomarker to assess ...
B-type natriuretic peptide (BNP) and N-terminal B-type natriuretic peptide precursor (NT-proBNP) are biomarkers of cardiac function, as well as the preferred biomarkers for the diagnosis and differential diagnosis of heart failure, disease severity and prognosis assessment, and have been recommended as Level I by several clinical practice guidelines. BNP is mainly degraded in large blood ves...
Major risk factors for cardiovascular disease Hypertension: one of the main controllable risk factors, accounting for 50% of cardiovascular disease morbidity and 20% of deaths, but the awareness rate is only 46.9%, and the blood pressure control rate is even lower to 15.3%. Dyslipidemia: Studies have shown that the awareness, treatment and control rates of dyslipidemia in ≥ 18-year-olds need to...
World Stroke Day is observed on October 29 to underscore the serious nature and high rates of stroke, raise awareness of the prevention and treatment of the condition, and ensure better care and support for survivors. Stroke and platelet function Stroke refers to an acute cerebrovascular disease caused by the sudden rupture of blood vessels in the brain or the sudden interruption of blood flo...
Introduction: In the rapidly evolving field of diagnostics, advanced technologies are paving the way for faster, more accurate, and convenient testing solutions. As a leading manufacturer and exporter of dry-chemistry chemiluminescence immunoassay analyzers and assay kits, we are proud to introduce a breakthrough solution that addresses the key challenges in diagnostic testing. Our cutting-edge pl...
In the fast-evolving landscape of healthcare, Point-of-Care Testing (POCT) has emerged as a game-changer. This innovative approach allows healthcare providers to conduct tests at or near the site of patient care, leading to quicker diagnosis and treatment. One of the standout advantages of POCT is its ability to streamline processes, offering numerous benefits that enhance patient care and operati...
In the realm of laboratory testing, the evolution from Fluorescence Immunoassay (FIA) to Chemiluminescence Immunoassay (CLIA) represents a significant advancement. This transition not only enhances the accuracy of test results but also transforms the efficiency of testing processes in healthcare settings. As labs seek to improve their diagnostic capabilities, understanding the benefits of upgradin...